Adjuvant chemotherapy in non-small cell lung cancer (NSCLC)

Annals of Oncology

Volumn 18, Issue SUPPL. 9, 2007, Pages

  Felip, E ^a   Cedres S ^a   Peralta, S ^a   Prat, A ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BCG VACCINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MITOMYCIN C; NAVELBINE; PACLITAXEL; PLATINUM COMPLEX; UFT; VINBLASTINE; VINDESINE;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; CONFERENCE PAPER; FEBRILE NEUTROPENIA; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; POSTOPERATIVE CARE; PRIORITY JOURNAL; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; LUNG TUMOR; META ANALYSIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; META-ANALYSIS; NEOPLASM STAGING; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 36049027446     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm309     Document Type: Conference Paper

References (18)

1. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30.
2. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non small cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998; 352: 257-263.
3. Keller SM, Adak S, Wagner H et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 2000; 343: 1217-1222.
4. Holmes EC, Gail M. Surgical adjuvant therapy for stage II and III adenocarcinoma and large-cell undifferentiated carcinoma. J Clin Oncol 1986; 4: 710-715.
5. Feld R, Rubinstein L, Thomas PA. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group. J Nat Cancer Inst 1993; 85: 299-306.
6. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899-909.
7. Scagliotti GV, Fossati R, Torri V et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer. J Nat Cancer Inst 2003; 95: 1453-1461.
8. Waller D, Peake MD, Stephens RJ et al. Chemotherapy for patients with non-small cell lung cancer. The surgical setting of the Big Lung Trial. Eur J CardioThorc Surg 2004; 26: 173-182.
9. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350: 351-360.
10. Olaussen K, Dunant A, Fouret P et al. DNA repair by ERCC! In Non-Small Cell Lung Cancer and cisplatin based adjuvant chemotherapy, N Engl J Med 2006; 355: 983-991.
11. Winton TL, Livingston R, Johnson D et al. Vinorelbine plus Gisplatin vs. Observation in Resected Non-Small-Cell Lung Cancer. N Engl J Med 2005; 352:2589-2597.
12. Douillard A Rosell R, De Lena M et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer. Lancet Oncol 2006; 7: 719-727.
13. Pignon J, Tribodet H, Scagliotti G et al. lung adjuvant cisplatin evaluation. A pooled analysis of five randomized clinical trials including 4584 patients. Proc Am Soc Clin Oncol 2006; 24: 366S (abstract 7008).
14. Strauss GM, Hemdon J, Maddaus MA et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633. Proc Am Soc Clin Oncol 2006; 24: 365 (abstract 7007).
15. Wada H, Miyahara R, Tanaka F et al. Adjuvant chemotherapy after complete resection in non-small cell lung cancer. J Clin Oncoll 1996; 14: 1048-1054.
16. Kato H, Ichinose Y, Ohta M et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004; 350: 1713-1721.
17. Potti A, Mukherjee S, Petersen R et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006; 355: 570-580.
18. Chen HY, Yu SL, Chen CH et al, A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007; 356: 11-20.